Ubs Group Ag Biolife Solutions Inc Transaction History

Ubs Group Ag

  • $555 Billion
  • Q2 2025

A detailed history of Ubs Group Ag transactions in Biolife Solutions Inc stock. As of the latest transaction made, Ubs Group Ag holds 269,221 shares of BLFS stock, worth $7.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
269,221
Previous 216,554 24.32%
Holding current value
$7.36 Million
Previous $4.95 Million 17.25%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$20.64 - $25.27 $1.09 Million - $1.33 Million
52,667 Added 24.32%
269,221 $5.8 Million
Q1 2025

May 13, 2025
SELL
$22.84 - $28.49 $2.66 Million - $3.32 Million
-116,378 Reduced 34.96%
216,554 $4.95 Million
Q4 2024

Feb 14, 2025
BUY
$20.47 - $27.47 $6.51 Million - $8.74 Million
318,002 Added 2129.95%
332,932 $8.64 Million
Q3 2024

Nov 14, 2024
BUY
$19.19 - $26.52 $6,620 - $9,149
345 Added 2.37%
14,930 $373,000
Q2 2024

Aug 13, 2024
SELL
$15.14 - $22.99 $169,689 - $257,671
-11,208 Reduced 43.45%
14,585 $312,000
Q1 2024

May 13, 2024
SELL
$15.35 - $18.82 $49,534 - $60,732
-3,227 Reduced 11.12%
25,793 $478,000
Q4 2023

Feb 09, 2024
BUY
$8.99 - $16.86 $259,712 - $487,068
28,889 Added 22052.67%
29,020 $471,000
Q3 2023

Nov 09, 2023
SELL
$10.81 - $22.96 $302,182 - $641,823
-27,954 Reduced 99.53%
131 $1,000
Q2 2023

Aug 11, 2023
BUY
$17.19 - $24.34 $157,632 - $223,197
9,170 Added 48.48%
28,085 $620,000
Q1 2023

May 12, 2023
BUY
$17.67 - $26.07 $59,795 - $88,220
3,384 Added 21.79%
18,915 $411,000
Q4 2022

Feb 08, 2023
BUY
$16.95 - $25.07 $162,787 - $240,772
9,604 Added 162.04%
15,531 $282,000
Q3 2022

Nov 10, 2022
BUY
$14.64 - $26.7 $35,516 - $64,774
2,426 Added 69.29%
5,927 $135,000
Q2 2022

Aug 10, 2022
SELL
$10.54 - $24.2 $20,616 - $47,335
-1,956 Reduced 35.84%
3,501 $48,000
Q1 2022

May 16, 2022
SELL
$20.81 - $37.29 $106,880 - $191,521
-5,136 Reduced 48.48%
5,457 $123,000
Q4 2021

Feb 14, 2022
SELL
$32.99 - $58.55 $102,829 - $182,500
-3,117 Reduced 22.74%
10,593 $395,000
Q3 2021

Nov 15, 2021
BUY
$42.03 - $60.5 $384,112 - $552,909
9,139 Added 199.93%
13,710 $580,000
Q2 2021

Aug 13, 2021
SELL
$29.51 - $44.62 $542,157 - $819,758
-18,372 Reduced 80.08%
4,571 $204,000
Q1 2021

May 12, 2021
SELL
$32.95 - $44.24 $1.36 Million - $1.82 Million
-41,233 Reduced 64.25%
22,943 $826,000
Q4 2020

Feb 11, 2021
BUY
$27.5 - $45.75 $1.51 Million - $2.51 Million
54,882 Added 590.51%
64,176 $2.56 Million
Q3 2020

Nov 12, 2020
SELL
$16.04 - $28.94 $76,350 - $137,754
-4,760 Reduced 33.87%
9,294 $269,000
Q2 2020

Jul 31, 2020
SELL
$9.2 - $17.06 $16,422 - $30,452
-1,785 Reduced 11.27%
14,054 $230,000
Q1 2020

May 01, 2020
BUY
$8.36 - $17.03 $28,474 - $58,004
3,406 Added 27.39%
15,839 $151,000
Q4 2019

Feb 14, 2020
BUY
$14.59 - $18.9 $90,837 - $117,671
6,226 Added 100.31%
12,433 $201,000
Q3 2019

Nov 14, 2019
BUY
$15.7 - $20.98 $78,547 - $104,962
5,003 Added 415.53%
6,207 $104,000
Q2 2019

Aug 14, 2019
BUY
$15.2 - $19.42 $18,300 - $23,381
1,204 New
1,204 $20,000
Q4 2018

Feb 14, 2019
SELL
$9.5 - $17.17 $14,364 - $25,961
-1,512 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$14.99 - $25.48 $19,352 - $32,894
-1,291 Reduced 46.06%
1,512 $27,000
Q2 2018

Aug 14, 2018
BUY
$6.18 - $13.49 $4,838 - $10,562
783 Added 38.76%
2,803 $32,000
Q1 2018

May 15, 2018
BUY
$4.73 - $6.03 $9,554 - $12,180
2,020 New
2,020 $10,000
Q3 2017

Nov 14, 2017
SELL
$3.45 - $5.71 $462 - $765
-134 Closed
0 $0
Q2 2017

Aug 14, 2017
SELL
N/A
-205 Reduced 60.47%
134 $0
Q1 2017

Nov 14, 2017
BUY
N/A
339
339 $1,000

Others Institutions Holding BLFS

# of Institutions
205
Shares Held
50.4M
Call Options Held
0
Put Options Held
0
View Full List

About BIOLIFE SOLUTIONS INC

BLFS Quotes by TradingView
  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.17B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email